Command Palette

Search for a command to run...

Clinical Trials · NCT02231658

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

TerminatedPhase 1Liraglutide (Prohibited)
Phase
Phase 1
Recruitment status
Terminated
Sponsor
Profil Institut für Stoffwechselforschung GmbH
Enrollment
109
Start date
Jul 2015
Locations
2 sites, Germany
Primary endpoint
Change from baseline (week -1) in the number of reflux episodes
View Liraglutide compound reference